{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:31:01Z","timestamp":1787772661028,"version":"build-2784847793"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Malignant mesothelioma is an aggressive neoplasm arising from serosal lining and has a poor prognosis. Definite diagnosis requires confirmation through a biopsy; however, it is sometimes difficult on microscopic evaluation alone and requires the use of a wide panel of immunohistochemical markers. So, immunohistochemistry (IHC) is of paramount importance and must be routinely used for a definite diagnosis. Till date, very few studies on morphology and detailed IHC markers of mesothelioma have been reported from India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To analyze the histomorphological findings of malignant mesothelioma, study the utility and role of the various immunohistochemical markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>A total of 76 cases of mesotheliomas diagnosed at a tertiary cancer center in Udaipur were analyzed retrospectively from January 2015 to January 2020. Comprehensive data were analyzed including demographic, clinical, radiological, histopathological features along with a wide panel of IHC markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Mesothelioma occurs over a wide age range from 40 to 70 years. It most commonly involved pleura in 68 cases (89.47%) with very few cases from the peritoneum. On computed tomography (CT) scan, nodular pleural or peritoneal thickening was present. On microscopy, the most common histopathological type was epithelioid mesothelioma (58 cases, 74.3%) followed by sarcomatous (9 cases, 12.8%), deciduoid (6 cases, 8.6%), and 3 cases of biphasic (4.3%). On IHC, WT1, mesothelin, and calretinin markers were positive in 85.91%, 80%, and 93.33% cases of mesothelioma, respectively. Other markers were helpful to rule out differential diagnosis in difficult scenarios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Therefore, the correlation of histopathology with clinico-radiological findings and judicious use of a panel of IHC markers is required for routine evaluation and definite diagnosis. IHC is also useful in situations with similar morphological spectrum in specific locations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_617_20","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T04:19:44Z","timestamp":1717042784000},"page":"655-663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Malignant mesothelioma"],"prefix":"10.4103","volume":"64","author":[{"given":"Tarang","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Aswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20240829","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: A Surveillance, epidemiology, and end results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemio"},{"key":"R3-7-20240829","first-page":"1433","article-title":"Malignant mesothelioma","volume":"29","author":"Ahmed","year":"2013","journal-title":"Pak J Med Sci"},{"key":"R4-7-20240829","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0019-5278.146897","article-title":"Global mesothelioma epidemic: Trend and features","volume":"18","author":"Bianchi","year":"2014","journal-title":"Indian J Occup Environ Med"},{"key":"R5-7-20240829","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijc.IJC_584_17","article-title":"Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India","volume":"55","author":"Hui","year":"2018","journal-title":"Indian J Cancer"},{"key":"R6-7-20240829","doi-asserted-by":"crossref","first-page":"825","DOI":"10.12659\/MSM.890020","article-title":"Malignant pleural mesothelioma: A single-centre experience in Turkey","volume":"20","author":"Sezer","year":"2014","journal-title":"Med Sci Monit"},{"key":"R7-7-20240829","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-5002(10)80011-X","article-title":"Clinical features and current treatment of diffuse malignant pleural mesothelioma","volume":"12","author":"Rusch","year":"1995","journal-title":"Lung Cancer"},{"key":"R8-7-20240829","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma interest group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R9-7-20240829","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jcp.55.9.662","article-title":"Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: A critical evaluation of new antibodies","volume":"55","author":"Abutaily","year":"2002","journal-title":"J Clin Pathol"},{"key":"R10-7-20240829","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of Malignant Mesothelioma 2017 update of the consensus statement from the International Mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R11-7-20240829","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jso.2930490313","article-title":"Primary pleural mesotheliomas in South India: A 25-year study","volume":"49","author":"Kini","year":"1992","journal-title":"J Surg Oncol"},{"key":"R12-7-20240829","first-page":"1208","article-title":"Malignant pleural mesothelioma","volume":"49","author":"Nadgouda","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"R13-7-20240829","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/rg.241035058","article-title":"Malignant pleural mesothelioma: Evaluation with CT, MR imaging, and PET","volume":"24","author":"Zhen","year":"2004","journal-title":"RadioGraphics"},{"key":"R14-7-20240829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21037\/jtd.2017.10.09","article-title":"Clinical diagnosis of malignant pleural mesothelioma","volume":"10","author":"Bianco","year":"2018","journal-title":"Thorac Dis"},{"key":"R15-7-20240829","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1759-7714.2010.00033.x","article-title":"Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data","volume":"2","author":"Adel","year":"2011","journal-title":"Thorac Cancer"},{"key":"R16-7-20240829","first-page":"205","article-title":"Expression of mesothelial markers in malignant mesotheliomas: An immunohistochemical evaluation of 173 cases","volume":"55","author":"Soomro","year":"2005","journal-title":"J Pakistan Med Assoc"},{"key":"R17-7-20240829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1746-1596-5-47","article-title":"Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry","volume":"5","author":"Sandeck","year":"2010","journal-title":"Diagn Pathol"},{"key":"R18-7-20240829","first-page":"A2884","article-title":"Clinical and histological analysis of malignant mesothelioma: A comprehensive statewide study","volume":"52","author":"Pferdmenges","year":"2018","journal-title":"Eur Respir J"},{"key":"R19-7-20240829","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R20-7-20240829","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jcp.2005.029652","article-title":"My approach to the diagnosis of mesothelial lesions","volume":"59","author":"Butnor","year":"2006","journal-title":"J Clin Pathol"},{"key":"R21-7-20240829","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","article-title":"Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: Identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity","volume":"19","author":"Yaziji","year":"2006","journal-title":"Mod Pathol"},{"key":"R22-7-20240829","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2559.2002.01352.x","article-title":"Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum","volume":"40","author":"Attanoos","year":"2002","journal-title":"Histopathology"},{"key":"R23-7-20240829","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: A comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"R24-7-20240829","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"R25-7-20240829","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.2008.108","article-title":"Immunophenotyping of serous carcinoma of female genital tract","volume":"21","author":"Nofech-Mozes","year":"2008","journal-title":"Mod Pathol"},{"key":"R26-7-20240829","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ordonez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R27-7-20240829","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.humpath.2005.02.014","article-title":"Mesothelioma with clear cell features: An ultrastructural and immunohistochemical study of 20 cases","volume":"36","author":"Ordonez","year":"2005","journal-title":"Hum Pathol"},{"key":"R28-7-20240829","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.MP.0000052103.13730.20","article-title":"Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumours tested using tissue microarrays and conventional tissue sections","volume":"16","author":"Fan","year":"2003","journal-title":"Mod Pathol"},{"key":"R29-7-20240829","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinoma of the lung: A comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"R30-7-20240829","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAI.0b013e3182980544","article-title":"p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: Comparison with p63, cytokeratin 5\/6, desmocollin-3, and SOX2","volume":"22","author":"Tatsumori","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R31-7-20240829","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2559.2003.01583.x","article-title":"Sarcomatoid mesothelioma and its histological mimics: A comparative immunohistochemical study","volume":"42","author":"Lucas","year":"2003","journal-title":"Histopathology"},{"key":"R32-7-20240829","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2559.2000.00981.x","article-title":"Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms","volume":"37","author":"Attanoos","year":"2000","journal-title":"Histopathology"},{"key":"R33-7-20240829","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"International Mesothelioma interest group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma interest group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R34-7-20240829","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: Are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R35-7-20240829","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.3800067","article-title":"Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers","volume":"17","author":"Trupiano","year":"2004","journal-title":"Mod Pathol"},{"key":"R36-7-20240829","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: Evidence-based guidelines from the International Mesothelioma panel and the Mesopath National reference center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Hum Pathol"},{"key":"R37-7-20240829","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","article-title":"GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung","volume":"41","author":"Berg","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R38-7-20240829","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, A novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"30","author":"Amatya","year":"2017","journal-title":"Mod Pathol"},{"key":"R39-7-20240829","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R40-7-20240829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/110.2.191","article-title":"The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: A histologic and immunohistochemical analysis of 31 cases including p53 immunostaining","volume":"110","author":"Mangano","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"R41-7-20240829","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12885-016-2745-8","article-title":"Malignant mesothelioma of the pleura with desmoplastic histology: A case series and literature review","volume":"16","author":"Hashimoto","year":"2016","journal-title":"BMC Cancer"},{"key":"R42-7-20240829","doi-asserted-by":"crossref","first-page":"633","DOI":"10.21873\/invivo.11521","article-title":"Clinicopathological characteristics of well-differentiated papillary mesothelioma of the peritoneum: A single-institutional experience of 12 cases","volume":"33","author":"Kim","year":"2019","journal-title":"In Vivo"},{"key":"R43-7-20240829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.anndiagpath.2010.08.005","article-title":"Malignant mesothelioma with prominent adenomatoid features: A clinicopathologic and immunohistochemical study of 10 cases","volume":"15","author":"Weissferdt","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"R44-7-20240829","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/019131290505176","article-title":"Lymphohistiocytoid mesothelioma: A clinical, immunohistochemical and ultrastructural study of four cases and literature review","volume":"28","author":"Yao","year":"2004","journal-title":"Ultrastruct Pathol"},{"key":"R45-7-20240829","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lungcan.2019.02.004","article-title":"Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia","volume":"130","author":"Yoshimura","year":"2019","journal-title":"Lung Cancer"},{"key":"R46-7-20240829","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/his.13321","article-title":"Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours","volume":"71","author":"Yoshimura","year":"2017","journal-title":"Histopathology"},{"key":"R47-7-20240829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"key":"R48-7-20240829","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2018.11.032","article-title":"Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International conference of the International Mesothelioma interest group","volume":"127","author":"Chapel","year":"2019","journal-title":"Lung Cancer"},{"key":"R49-7-20240829","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1066896913491320","article-title":"Claudin-4 as a marker for distinguishing malignant mesothelioma from lung carcinoma and serous adenocarcinoma","volume":"21","author":"Ohta","year":"2013","journal-title":"Int J Surg Pathol"},{"key":"R50-7-20240829","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.pathol.2018.05.002","article-title":"Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: Prognostic implications","volume":"50","author":"Forest","year":"2018","journal-title":"Pathology"},{"key":"R51-7-20240829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl Lung Cancer Res"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_617_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:54Z","timestamp":1787771274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_617_20"}},"subtitle":["A clinicopathological study of 76 cases with emphasis on immunohistochemical evaluation along with review of the literature"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_617_20","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}